Krystal Biotech, Inc. - COM (KRYS)

Historical Portfolio Holders from Q3 2017 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
28M
Holdings value Q3 2024
$5.1B
Value change Q3 2024
-$100M
Grand Portfolio weight change Q3 2024
0%
Number of holders
276
Number of buys Q3 2024
153
Number of sells Q3 2024
-104
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 28M $5.1B -$100M $182.03 280
2024 Q2 28.5M $5.23B +$661M $183.64 246
2024 Q1 25.2M $4.48B +$174M $177.93 234
2023 Q4 24.4M $3.02B +$41.1M $124.06 194
2023 Q3 23.8M $2.76B +$90.5M $116.00 186
2023 Q2 23M $2.7B +$257M $117.40 186
2023 Q1 21M $1.68B +$9.32M $80.06 160
2022 Q4 20.9M $1.66B -$15.6M $79.22 154
2022 Q3 20.8M $1.45B -$1.42M $69.70 143
2022 Q2 20.8M $1.36B +$17.5M $65.66 129
2022 Q1 20.5M $1.37B +$24.5M $66.54 129
2021 Q4 19.3M $1.35B +$209M $69.95 136
2021 Q3 16.3M $850M -$12.1M $52.21 119
2021 Q2 16.4M $1.12B -$7.23M $68.00 117
2021 Q1 16.5M $1.27B +$202M $77.04 115
2020 Q4 13.9M $835M -$16.2M $60.00 107
2020 Q3 14.4M $619M +$11.3M $43.05 99
2020 Q2 14.1M $585M +$106M $41.42 109
2020 Q1 11.5M $498M -$9.39M $43.24 88
2019 Q4 11.4M $631M +$15.8M $55.38 89
2019 Q3 11.2M $388M +$48.3M $34.73 83
2019 Q2 9.77M $393M +$131M $40.27 75
2019 Q1 6.65M $219M +$15.5M $32.90 56
2018 Q4 6.21M $129M +$73.1M $20.78 45
2018 Q3 2.72M $47.6M +$6.01M $17.58 21
2018 Q2 2.39M $35.5M -$7.83M $14.87 16
2018 Q1 3.08M $31M -$1.63M $10.09 12
2017 Q4 3.24M $34M +$1.03M $10.52 13
2017 Q3 3.14M $31.3M +$31.3M $9.97 13